VGL101
Product Specifications
Target
Others, Apoptosis
Related Pathways
Apoptosis, Others
Bioactivity
VGL101 is a human IgG1 monoclonal antibody (mAb) that targets TREM-2. It acts as a pSYK agonist with an EC50 of 0.77 nM. Under ALSP pathological conditions, VGL101 enhances the survival of microglia and monocyte-derived macrophages, inhibits apoptosis, and aids in restoring cell morphology to resemble the normal activated CSF1R state. It is applicable in leukoencephalopathy research. Recommended isotype control: Human IgG1 kappa, Isotype Control.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1023434-01 0.02 mg (E-Coli)
Recombinant Caenorhabditis briggsae Putative protein-tyrosine sulfotransferase (tpst-2)
Sign In for Pricing
View Details 
MBS1023434-02 0.02 mg (Yeast)
Recombinant Caenorhabditis briggsae Putative protein-tyrosine sulfotransferase (tpst-2)
Sign In for Pricing
View Details 
MBS1023434-03 0.1 mg (E-Coli)
Recombinant Caenorhabditis briggsae Putative protein-tyrosine sulfotransferase (tpst-2)
Sign In for Pricing
View Details MBS1023434-04 0.1 mg (Yeast)
Recombinant Caenorhabditis briggsae Putative protein-tyrosine sulfotransferase (tpst-2)
Sign In for Pricing
View Details MBS1023434-05 0.02 mg (Baculovirus)
Recombinant Caenorhabditis briggsae Putative protein-tyrosine sulfotransferase (tpst-2)
Sign In for Pricing
View Details MBS1023434-06 0.02 mg (Mammalian-Cell)
Recombinant Caenorhabditis briggsae Putative protein-tyrosine sulfotransferase (tpst-2)
Sign In for Pricing
View Details